MRF Blog

#EyeGetDilated: Alina Itkis

December 8, 2017 | Categories: Ocular Melanoma, Patient Stories

#EyeGetDilated because… I want to continue exploring the world with my mom. I know this statement may not exactly make sense, so let me explain.

In J.B.'s Words: A Face of Mucosal Melanoma

November 30, 2017 | Categories: Patient Stories, Types of Melanoma

J.B. Ward is one of the 1% of melanoma patients with mucosal melanoma. Together, J.B., the MRF and the mucosal melanoma community have launched a mucosal melanoma fundraising campaign with proceeds used to create #OutoftheShadows, an educational video highlighting mucosal melanoma patients and shining a light on this rare form of melanoma. No one should have to feel alone after receiving a melanoma diagnosis.

#EyeGetDilated: Deborah Smith

November 22, 2017 | Categories: Ocular Melanoma, Patient Stories

Guest blog post by OM survivor and #EyeGetDilated advocate, Deborah Smith:

#EyeGetDilated: William Karp

November 15, 2017 | Categories: Causes, Ocular Melanoma, Patient Stories

Guest blog post by OM survivor and #EyeGetDilated advocate, William Karp:

Near Life Experiences

October 25, 2017 | Categories: Ocular Melanoma, Patient Stories

Ocular melanoma survivor and 2017 MRF Courage Award recipient Aaron Davis on the importance of "near life experiences."

The MRF Welcomes CEO Elly Brtva

September 29, 2017 | Categories: News

The Board of Directors of the Melanoma Research Foundation (MRF) is excited to announce that Eleanor (Elly) Brtva will assume the role of CEO of the Melanoma Research Foundation, effective immediately. Elly brings a wealth of knowledge, experience and dedication to the MRF and we are eager to welcome her to the organization.

Congress Must Protect DoD Medical Research Funding

September 26, 2017 | Categories: News, Policy, Research

Since 1992, the Department of Defense Congressionally-Directed Medical Research Program (CDMRP) has transformed healthcare for service members and the American public through innovative and impactful biomedical research. As of 2017, Congress has, on a bipartisan basis, provided the CDMRP with $11.9 billion in funding to support high impact, high risk, and high gain projects that other agencies and private investors may be unwilling to fund.

Apply for the Medical Student Research Award

September 1, 2017 | Categories: News, Research

The Melanoma Reserach Foundation (MRF) is now accepting applications for the 2018 Medical Student Research Award. The MRF has been awarding this research grant since 2011 and in this time 35 grants have been awarded to students at 24 different institutions. The purpose of the Medical Student Research Award is to promote scientific inquiry and research opportunities to medical students early in their careers by funding concise clinical or laboratory-based research projects focused on better understanding the prevention, biology, and treatment of melanoma.

What's Next: 

FDA Expands Approval of Ipilimumab For Pediatric Melanoma Patients

August 3, 2017 | Categories: News, Research, Treatment

Last week the United States Food and Drug Administration (FDA) expanded approval of Yervoy (ipilimumab) to include pediatric patients ages 12 years and older with unresectable or metastatic melanoma. Yervoy, a monoclonal antibody that activates the immune system by blocking the CTLA-4 receptor, was first approved in 2011 to treat unresectable or metastatic melanoma in adults.

Indoor Tanning Association Ends Operations

August 2, 2017 | Categories: News, Policy, Prevention

Statement from the Melanoma Research Foundation

Pages